Eichholz Lab

Fred Hutchinson Cancer Center

Seattle · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2025

Selective Targeting of the PD-1+ HIV/SIV reservoir with novel anti-PD-1 chimeric antigen receptor T cells

Project Summary/Abstract Human immunodeficiency virus infects cells of the immune system and, if left untreated leads to the development of acquired immunodeficiency syndrome and death. With the advent of antiretrovirals, HIV infection has turned into a chronic infection. However, tools and therapeutics to dissect and deplete SIV/HIV latent reservoirs during combination antiretroviral therapy (ART) to interrogate their importance in defining reservoir dynamics are limited and are a focus of this application. Programmed cell death protein 1 (PD-1) is an immune checkpoint protein expressed on latently infected CD4 T cells and in particular T follicular helper (TFH) cells. TFH cells reside in…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Fred Hutchinson Cancer Center